Evidence map›Paper›PMID 30662960›Full record

ArticleBiochemistry and biophysics reports2019

TRPC6 inactivation does not affect loss of renal function in nephrotoxic serum glomerulonephritis in rats, but reduces severity of glomerular lesions.

Eun Young Kim, Parisa Yazdizadeh Shotorbani, Stuart E Dryer

Open access · goldAbstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Calcium signalling and transport in the kidney.Nature reviews. Nephrology · 2024
    Review
  6. Roles of TRP and PIEZO receptors in autoimmune diseases.Expert reviews in molecular medicine · 2024
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Transmembrane insertases andThe Journal of biological chemistry · 2019
    Article
  17. Review
  18. c-Src is in the effector pathway linking uPAR and podocyte injury.The Journal of clinical investigation · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Eun Young KimDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Parisa Yazdizadeh ShotorbaniDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Stuart E DryerDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
University of Houston · US

Funding

Pathophysiology of FSGSR01DK104708 · NIDDK · UNIVERSITY OF HOUSTON · PI DRYER, STUART E · 2016 to 2024
$2.7M
NIDDK NIH HHS R01 DK104708
6 · The paper itself

Abstract

Canonical transient receptor potential-6 (TRPC6) channels have been implicated in a variety of chronic kidney diseases including familial and acquired forms of focal and segmental glomerulosclerosis (FSGS) and renal fibrosis following ureteral obstruction. Here we have examined the role of TRPC6 in progression of inflammation and fibrosis in the nephrotoxic serum (NTS) model of crescentic glomerulonephritis. This was assessed in rats with non-functional TRPC6 channels due to genomic disruption of an essential domain in TRPC6 channels (

Indexed as

BUN, blood urea nitrogenChronic kidney diseaseCKD, chronic kidney diseaseFSGS, focal and segmental glomerulosclerosisGBM, glomerular basement membraneGlomerulonephritisIL-1β, interleukin 1βNLRP3, NOD-like receptor pyrin domain containing-3 proteinNTS, nephrotoxic serumPAN, puromycin amino nucleosidePAS, periodic acid-Schiff’s stainRenal fibrosisSMA, α-smooth muscle actinsuPAR, soluble urokinase receptorTCA, trichloroacetic acidTNF, tumor necrosis factorTRPC3, canonical transient receptor potential-3 channelTRPC5, canonical transient receptor potential-5 channelTRPC6TRPC6, canonical transient receptor potential-6 channelUUO, unilateral ureteral obstruction

Identifiers

PMID30662960
PMCPMC6325086
OpenAlexW2909509310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.